At a cost of $9 billion a year, over 2 million patient experiences, and 90,000 deaths, Hospital Associated Infections (HAIs) are a significan cause of patient harm. HAI is a “syndrome” of policies, effects and reservoirs of invasive and non-invasive causes.
We have partnered with enterprising global vendors to develop innovative programs and technologies for controlling the spread of infection; our program provides a sustainable nanotechnology protective barrier and best available technologies to inhibit a broad spectrum of microbial pathogens. Prevailing cleaning processes create “gaps” in the infection control process which promotes microbial regrowth.
Utilizing these best available technologies, StarSource targets the non-invasive HAI reservoirs such as the medical linens and high touch point surfaces in the patient environment, and when our program is incorporated into the EVS cleaning process with ICP protocols, a system is created to provide sustainable inhibition to microbial growth ranging from medical linens to patient room high touch point surfaces.
Resulting in: